Skip to Content
Merck
  • Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.

Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.

Proceedings of the National Academy of Sciences of the United States of America (2016-12-14)
Andrew C Wang, Elizabeth H Jensen, Jessica E Rexach, Harry V Vinters, Linda C Hsieh-Wilson
ABSTRACT

O-GlcNAc glycosylation (or O-GlcNAcylation) is a dynamic, inducible posttranslational modification found on proteins associated with neurodegenerative diseases such as α-synuclein, amyloid precursor protein, and tau. Deletion of the O-GlcNAc transferase (ogt) gene responsible for the modification causes early postnatal lethality in mice, complicating efforts to study O-GlcNAcylation in mature neurons and to understand its roles in disease. Here, we report that forebrain-specific loss of OGT in adult mice leads to progressive neurodegeneration, including widespread neuronal cell death, neuroinflammation, increased production of hyperphosphorylated tau and amyloidogenic Aβ-peptides, and memory deficits. Furthermore, we show that human cortical brain tissue from Alzheimer's disease patients has significantly reduced levels of OGT protein expression compared with cortical tissue from control individuals. Together, these studies indicate that O-GlcNAcylation regulates pathways critical for the maintenance of neuronal health and suggest that dysfunctional O-GlcNAc signaling may be an important contributor to neurodegenerative diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-O-GlcNAc Transferase (TI-14) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Sudan Black B, certified by the Biological Stain Commission
Sigma-Aldrich
Thioflavine S, practical grade
Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid